Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - Εμβόλια - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older.  spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.

Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - Εμβόλια - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. Η χρήση αυτού του εμβολίου θα πρέπει να γίνεται σύμφωνα με τις επίσημες συστάσεις.

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

tillotts pharma gmbh, germany warmbacher str. 80, 79618 rheinfelden baden 0049 7623 96651 979 - budesonide - tb.s.r.sus (ΔΙΣΚΙΟ ΚΑΙ ΔΙΑΛΥΤΗΣ ΓΙΑ ΠΑΡΑΣΚΕΥΗ ΕΝΑΙΩΡΗΜΑΤΟΣ ΑΠΟ ΤΟΥ ΟΡΘΟΥ) - 2,3mg/single dose - budesonide 2,3mg - budesonide

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

zwitter pharmaceuticals ΕΠΕ, greece Λεωφ. Πεντέλης 34-36,, 152 34 210 6821098 - hypromellose - ey.dr.s.sd (ΟΦΘΑΛΜΙΚΕΣ ΣΤΑΓΟΝΕΣ, ΔΙΑΛΥΜΑ ΜΙΑΣ ΔΟΣΗΣ) - 1,6mg/0,5ml single d - hypromellose 3,2mg - hypromellose

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

angelini pharma hellas ΑΝΩΝΥΜΗ ΒΙΟΜΗΧΑΝΙΚΗ & ΕΜΠΟΡΙΚΗ ΕΤΑΙΡΕΙΑ ΠΑΡΑΓΩΓΗΣ & ΕΜΠΟΡΙΑΣ ΦΑΡΜΑΚΩΝ Δ.Τ. angelini pharma hellas - calcium folinate - ΚΟΝΙΣ ΚΑΙ ΔΙΑΛΥΤΗΣ ΓΙΑ ΠΟΣΙΜΟ ΔΙΑΛΥΜΑ - 15mg/single dose - 0001492188 calcium folinate 16.200000 mg - calcium folinate

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

tillotts pharma italy s.r.l., italy corso vercelli 40, 20145 milano (mi) - mesalazine - rec.sus (ΟΡΘΙΚΟ ΕΝΑΙΩΡΗΜΑ) - 4g/single dose - mesalazine 40mg - mesalazine

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

ΝΟΡΜΑ ΕΛΛΑΣ Α.Ε. ΜΕΝΑΝΔΡΟΥ 54, 104 31 104 31, ΑΘΗΝΑ 5222282 - levocarnitine - or.sol.sd (ΔΙΑΛΥΜΑ ΠΟΣΙΜΟ ΣΕ ΣΥΣΚΕΥΑΣΙΑ ΜΙΑΣ ΔΟΣΗΣ) - 1g/10ml(single dose) - levocarnitine 100mg - levocarnitine

Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

laboratoires thea (0000008132) 12 rue louis bleriot, clermont-ferrand cedex 2, 63017 - latanoprost; timolol maleate - eye drops, solution in single-dose container - (50mcg/5mg)/ml - latanoprost (8000001603) 0,05mg; timolol maleate (0025839752) 6,83mg

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

mundipharma corporation (ireland) limited, ireland millbank house, arkle road, d18c6r3 dublin 18 - naloxone hydrochloride dihydrate - naspr.sol (ΡΙΝΙΚΟ ΕΚΝΕΦΩΜΑ, ΔΙΑΛΥΜΑ) - 1,8 mg/single-dose container - naloxone hydrochloride dihydrate 1,8mg - naloxone

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

sifi spa, aci s. antonio (ct), italy via ercole patti 36,, 95025 aci s. antonio (ct) - netilmicin sulfate; dexamethasone sodium phosphate - eye.gel (ΟΦΘΑΛΜΙΚΗ ΓΕΛΗ) - (3+1)mg/ml (single dose) - netilmicin sulfate 4,55mg; dexamethasone sodium phosphate 1,32mg - dexamethasone and antiinfectives